Table of Contents

company-logo

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

Hepion Pharmaceuticals Dividend Announcement

• Hepion Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Hepion Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Hepion Pharmaceuticals Dividend History

Hepion Pharmaceuticals Dividend Yield

Hepion Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Hepion Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Hepion Pharmaceuticals Financial Ratios

P/E ratio-0.18
PEG ratio-0.04
P/B ratio-10.00
ROE-505.74%
Payout ratio-0.00%
Current ratio1.30
Quick ratio1.30
Cash Ratio0.55

Hepion Pharmaceuticals Dividend FAQ

Does Hepion Pharmaceuticals stock pay dividends?
Hepion Pharmaceuticals does not currently pay dividends to its shareholders.
Has Hepion Pharmaceuticals ever paid a dividend?
No, Hepion Pharmaceuticals has no a history of paying dividends to its shareholders. Hepion Pharmaceuticals is not known for its dividend payments.
Why doesn't Hepion Pharmaceuticals pay dividends?
There are several potential reasons why Hepion Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Hepion Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Hepion Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Hepion Pharmaceuticals a dividend aristocrat?
Hepion Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Hepion Pharmaceuticals a dividend king?
Hepion Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Hepion Pharmaceuticals a dividend stock?
No, Hepion Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Hepion Pharmaceuticals stocks?
To buy Hepion Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Hepion Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.